Health & Environmental Research Online (HERO)


Print Feedback Export to File
5681326 
Journal Article 
Plasticizer Interaction With the Heart 
Jaimes, R; Mccullough, D; Siegel, B; Swift, L; Mcinerney, D; Hiebert, J; Perez-Alday, EA; Trenor, B; Sheng, J; Saiz, J; Tereshchenko, LG; Posnack, NG 
2019 
Yes 
Circulation: Arrhythmia and Electrophysiology
ISSN: 1941-3149 
Lippincott Williams and Wilkins 
12 
e007294 
English 
BACKGROUND: Phthalates are used as plasticizers in the manufacturing of flexible, plastic medical products. Patients can be subjected to high phthalate exposure through contact with plastic medical devices. We aimed to investigate the cardiac safety and biocompatibility of mono-2-ethylhexyl phthalate (MEHP), a phthalate with documented exposure in intensive care patients.

METHODS: Optical mapping of transmembrane voltage and pacing studies were performed on isolated, Langendorff-perfused rat hearts to assess cardiac electrophysiology after MEHP exposure compared with controls. MEHP dose was chosen based on reported blood concentrations after an exchange transfusion procedure.

RESULTS: Thirty-minute exposure to MEHP increased the atrioventricular node (147 versus 107 ms) and ventricular (117 versus 77.5 ms) effective refractory periods, compared with controls. Optical mapping revealed prolonged action potential duration at slower pacing cycle lengths, akin to reverse use dependence. The plateau phase of the action potential duration restitution curve steepened and became monophasic in MEHP-exposed hearts (0.18 versus 0.06 slope). Action potential duration lengthening occurred during late-phase repolarization resulting in triangulation (70.3 versus 56.6 ms). MEHP exposure also slowed epicardial conduction velocity (35 versus 60 cm/s), which may be partly explained by inhibition of Nav1.5 (874 and 231 µmol/L half-maximal inhibitory concentration, fast and late sodium current).

CONCLUSIONS: This study highlights the impact of acute MEHP exposure, using a clinically relevant dose, on cardiac electrophysiology in the intact heart. Heightened clinical exposure to plasticized medical products may have cardiac safety implications-given that action potential triangulation and electrical restitution modifications are a risk factor for early after depolarizations and cardiac arrhythmias. 
action potentials; electrophysiology; heart; plasticizer; plastics; mono 2 ethylhexylphthalate; phthalic acid; plasticizer; unclassified drug; mono-(2-ethylhexyl)phthalate; phthalic acid bis(2 ethylhexyl) ester; plasticizer; sodium channel; action potential; animal tissue; Article; biocompatibility; blood level; chemical composition; comparative study; electric potential; epicardium mapping; heart automaticity; heart electrophysiology; heart rate variability; heart ventricle conduction; human; human cell; isolated heart; nonhuman; priority journal; rat; repolarization; sinus rhythm; triangulation; adverse event; animal; biological model; computer simulation; devices; drug effect; equipment design; heart arrhythmia; heart muscle conduction system; heart rate; male; metabolism; pathophysiology; refractory period; risk assessment; Sprague Dawley rat; time factor; voltage sensitive dye imaging; Action Potentials; Animals; Arrhythmias, Cardiac; Computer Simulation; Diethylhexyl Phthalate; Equipment and Supplies; Equipment Design; Heart Conduction System; Heart Rate; Humans; Isolated Heart Preparation; Male; Models, Cardiovascular; Plasticizers; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Risk Assessment; Sodium Channels; Time Factors; Voltage-Sensitive Dye Imaging